Successful treatment of methimazole-induced agranulocytosis by granulocyte colony-stimulating factor. 1992

K Yokoyama, and T Sato, and S Nakajima, and M Chino, and S Komatsumoto, and M Nara, and S Okamoto

UI MeSH Term Description Entries
D008713 Methimazole A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. Methymazol,Thiamazole,1-Methyl-2-mercaptoimidazole,Favistan,Mercasolyl,Mercazol,Mercazole,Mercazolyl,Merkazolil,Methizol,Methylmercaptoimidazole,Metisol,Metizol,Strumazol,Tapazole,Thiamazol Henning,Thiamazol Hexal,Thimazol,Thyrozol,Tiamazol,Tirodril,1 Methyl 2 mercaptoimidazole,Henning, Thiamazol,Hexal, Thiamazol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D016179 Granulocyte Colony-Stimulating Factor A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines. Colony-Stimulating Factor, Granulocyte,G-CSF,Myeloid Growth Factor,Colony Stimulating Factor, Granulocyte,Factor, Granulocyte Colony-Stimulating,Factor, Myeloid Growth,Granulocyte Colony Stimulating Factor,Growth Factor, Myeloid

Related Publications

K Yokoyama, and T Sato, and S Nakajima, and M Chino, and S Komatsumoto, and M Nara, and S Okamoto
October 1989, Annals of internal medicine,
K Yokoyama, and T Sato, and S Nakajima, and M Chino, and S Komatsumoto, and M Nara, and S Okamoto
November 1994, Orvosi hetilap,
K Yokoyama, and T Sato, and S Nakajima, and M Chino, and S Komatsumoto, and M Nara, and S Okamoto
January 1997, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
K Yokoyama, and T Sato, and S Nakajima, and M Chino, and S Komatsumoto, and M Nara, and S Okamoto
August 1994, Journal of clinical psychopharmacology,
K Yokoyama, and T Sato, and S Nakajima, and M Chino, and S Komatsumoto, and M Nara, and S Okamoto
November 1993, The Journal of clinical endocrinology and metabolism,
K Yokoyama, and T Sato, and S Nakajima, and M Chino, and S Komatsumoto, and M Nara, and S Okamoto
June 1995, Recenti progressi in medicina,
K Yokoyama, and T Sato, and S Nakajima, and M Chino, and S Komatsumoto, and M Nara, and S Okamoto
January 1994, Thyroid : official journal of the American Thyroid Association,
K Yokoyama, and T Sato, and S Nakajima, and M Chino, and S Komatsumoto, and M Nara, and S Okamoto
November 1996, The American journal of psychiatry,
K Yokoyama, and T Sato, and S Nakajima, and M Chino, and S Komatsumoto, and M Nara, and S Okamoto
April 1992, British journal of haematology,
K Yokoyama, and T Sato, and S Nakajima, and M Chino, and S Komatsumoto, and M Nara, and S Okamoto
October 2017, Clinical case reports,
Copied contents to your clipboard!